Vitamin B6, Vascular Dysfunction and Adhesion Molecules in Sickle Cell Disease

Project: Research project

Project Details

Description

DESCRIPTION (provided by applicant): Sickle cell disease (SCD) is characterized by acute clinical manifestations, including painful crisis, acute chest syndrome, priapism, and stroke, as well as chronic irreversible damage to the heart, lungs, kidneys, eyes, spleen and femoral heads. Vascular injury and occlusion, primarily affecting the microvasculature, underlie most of these complications. Another characteristic of sickle cell patients, both adult and pediatric, is a high prevalence of low vitamin B6 status (exceeding 50%), as indicated by low plasma pyridoxal-5'- phosphate levels (
StatusFinished
Effective start/end date4/15/073/31/12

Funding

  • National Institutes of Health: $363,197.00
  • National Institutes of Health: $363,470.00
  • National Institutes of Health: $363,470.00
  • National Institutes of Health: $363,470.00

ASJC

  • Medicine(all)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.